Effects of Gut Peptides on Bone Remodeling
NCT03574064 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10
Last updated 2021-01-20
Summary
We will investigate effects of gut hormones on bone remodeling.
Conditions
- Healthy
Interventions
- OTHER
-
Glucagon-Like Peptide-2 (GLP-2)
Glucagon-Like Peptide-2 (GLP-2) injection.
- OTHER
-
Glucose-dependent insulinotropic polypeptide (GIP)
Glucose-dependent insulinotropic polypeptide (GIP) injection.
- OTHER
-
GLP-2+GIP
GLP-2+GIP injection.
- OTHER
-
Placebo
Placebo injection.
Sponsors & Collaborators
-
Hvidovre University Hospital
collaborator OTHER -
University of Copenhagen
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- DOUBLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 50 Years
- Max Age
- 80 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2018-06-01
- Primary Completion
- 2019-01-01
- Completion
- 2019-01-01
Countries
- Denmark
Study Locations
More Related Trials
-
Examination of the Postprandial Bone Remodeling in Persons With Reduced GIP-Receptor Activity
NCT02518737 ·Status: COMPLETED
-
The Insulin Response to the Gut Hormone GIP After Near-normalisation of Plasma Glucose in Patients With Type 2 Diabetes
NCT04228484 ·Status: COMPLETED ·Phase: NA
-
Effect of the Enteric Hormone Glucagon-Like Peptide (GLP-2) on the Intestinal Blood Flow in Patients With Short Bowel Syndrome
NCT00673751 ·Status: UNKNOWN ·Phase: NA
-
GIP/GLP-1 Co-Activity in Subjects With Obesity: Lowering of Food Intake
NCT02598791 ·Status: COMPLETED ·Phase: NA
-
The Effect of GIP, GLP-1 and GLP-2 in Individuals With Genetically Altered Receptor Function
NCT06194955 ·Status: COMPLETED ·Phase: NA
-
Glucose-Dependent Insulinotropic Polypeptide - Effects on Markers of Bone Turnover in Patients With Type 1 Diabetes
NCT03195257 ·Status: COMPLETED ·Phase: NA
-
Physiology of GIP(1-30)NH2 in Humans
NCT04792762 ·Status: COMPLETED ·Phase: NA
-
Delinieation of GIP's Effects During a Meal in Humans Using GIP Receptor Antagonisation (GA-4)
NCT03013296 ·Status: COMPLETED ·Phase: NA
-
GIP, GLP-1 and GLP-2 in Type 2 Diabetic Hyperglucagonemia
NCT00716170 ·Status: COMPLETED
-
Separate and Combined Extrapancreatic Effects of GIP and GLP-1
NCT06895408 ·Status: COMPLETED ·Phase: NA
-
The Role of Glucose-Dependent Insulinotropic Polypeptide in the Pathological Glucose Homeostasis Of Type 1 Diabetes
NCT03734718 ·Status: COMPLETED ·Phase: NA
-
GLP-1 Signaling in Truncally Vagotomized Subjects
NCT02940184 ·Status: UNKNOWN ·Phase: NA
-
GIP/GLP-1 Co-Activity in Subjects With Overweight and Type 2 Diabetes: Lowering of Food Intake
NCT03526289 ·Status: COMPLETED ·Phase: NA
-
The Effect of GLP-1 on the Inhibition of Glucagon Secretion
NCT01507597 ·Status: COMPLETED ·Phase: NA
-
Separate and Combined Extrapancreatic Effects of the Incretin Hormones
NCT05177653 ·Status: COMPLETED ·Phase: NA
-
Effect of Glucagon-like Peptide 2 on Gallbladder Motility After a Meal in Young, Healthy Male Subjects
NCT03682172 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
The Effects of GIP and GLP-2 on the Secretion of Glucagon in Patients With Type 1 Diabetes
NCT00732602 ·Status: COMPLETED ·Phase: NA
-
Location of GLP-1 Release
NCT02036710 ·Status: COMPLETED
-
Investigating Glucose Metabolism of LEAP2 With Total-body PET/CT
NCT06254365 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
The Effect of GLP-1 Receptor Agonist on Bone Metabolism in Patients With Diabetes Mellitus
NCT06182852 ·Status: NOT_YET_RECRUITING
-
The Role of GIP and GLP-2 in Postprandial Splanchnic Blood Flow Distribution and Metabolism
NCT05391581 ·Status: COMPLETED ·Phase: NA
-
The Importance of GLP-1 in Post RYGB Improvement in Glycaemic Control Type 2 Diabetic Subjects
NCT01579981 ·Status: COMPLETED ·Phase: NA
-
Effect of GIP After a Meal in Patients With Type 2 Diabetes
NCT03702660 ·Status: COMPLETED ·Phase: NA
-
GLP-1 Infusion and Long-Time Fasting
NCT00285896 ·Status: COMPLETED ·Phase: NA
-
Glucose-dependent Insulinotropic Polypeptide as a Safeguard Against Hypoglycemia in Patients With Type 1 Diabetes
NCT03556098 ·Status: COMPLETED ·Phase: NA